Skip to main content
Premium Trial:

Request an Annual Quote

UK University Taps Dotmatics ELN to Support Drug Discovery Research

Premium

Dotmatics said this week that University of Sussex has added Studies Notebook, the company's web-based electronic laboratory notebook, to its existing Dotmatics data management platform.

The software Dotmatics provides supports ongoing projects from the university's translational drug discovery group in areas such as hit identification and lead optimization. Simon Ward, a professor of medicinal chemistry and co-director of the group, said that the company's products enable "us to work very effectively and to process and analyze data in a highly efficient manner."

John Atack, a professor of molecular pharmacology and group co-director, described Dotmatics' platform as "a fully optimized and perfectly integrated addition to our existing chemoinformatics platform." It enables "us to access all of our data in a single web-based platform and allows our scientists to streamline their data entry, triage, and analysis," he said.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.